Showing results (11-20 of 231) with videos related to
Sort By:
Pageof 24
ISRN Oncology|November 18, 2011
Downregulation of the adenosine a2b receptor by RNA interference inhibits hepatocellular carcinoma cell growthHong-Jun Xiang, Fu-Lu Chai, De-Sheng Wang, et al.ISRN Oncology|November 18, 2011
Prepubertal daidzein exposure enhances mammary gland differentiation and regulates the expression of estrogen receptor-alpha and apoptotic proteinsPrachi Mishra, Anand Kar, R K KaleISRN Oncology|November 16, 2011
High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour PatientsSuvi Savola, Arto Klami, Samuel Myllykangas, et al.ISRN Oncology|November 16, 2011
Anti-inflammatory drugs reduce the risk of hepatocellular carcinoma developmentYasushi Rino, Kazuo TaraoISRN Oncology|November 16, 2011
Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate CancersNatalia Yu Anisimova, Andrey V Sosnov, Nadezhda E Ustyuzhanina, et al.ISRN Oncology|November 16, 2011
3-5 BI-RADs Microcalcifications: Correlation between MRI and Histological FindingsValeria Fiaschetti, Chiara Adriana Pistolese, Tommaso Perretta, et al.ISRN Oncology|November 16, 2011
Does radioiodine therapy in patients with differentiated thyroid cancer increase the frequency of another malignant neoplasm?Renata Midori Hirosawa, Monica Marivo, Juliana de Moura Leite Luengo, et al.ISRN Oncology|June 8, 2012
Epidemiological characteristics and survival studies of rhabdomyosarcoma in East egypt: a five-year multicenter studyM A Badr, Y A Al-Tonbary, A K Mansour, et al.ISRN Oncology|April 21, 2012
High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic VariablesFawzi Abdel-Rahman, Ayad Hussein, Mohammad Aljamily, et al.Pageof 24